Predicting Drying Conditions That Keep Proteins and Bioactive Molecules Stable

Drying is where a lot of hard-won biological material is lost. Freeze drying and spray drying both expose proteins and other bioactive molecules to stresses — ice formation, concentration, shear, heat, dehydration — that can cost activity in ways the process record does not show until stability testing. This write-up describes a generalized modelling pattern drawn from published process-engineering work; it is not a validated cycle recipe, and every product needs its own data.

The problem

A freeze-drying cycle is defined by a handful of settable parameters — freezing profile, shelf temperature, chamber pressure, hold times — but what matters is what those settings do to the product: whether the sublimation interface stays below the collapse or glass-transition temperature, how long primary drying actually takes, and how much moisture is left at the end [1][2].

Finding that empirically is expensive. Each cycle can run for days, consumes material that may only exist in gram quantities, and a conservative cycle that never fails can also be twice as long as it needs to be. Spray drying compresses the timescale but adds its own coupled variables — inlet and outlet temperature, feed rate, atomization, excipient system — that jointly set particle size, residual moisture, and the stress the molecule experiences [6].

How teams approach it

The established engineering approach is to model the process rather than to sweep it.

Mechanistic heat- and mass-transfer models of primary drying predict product temperature and drying time from vial heat transfer coefficients and dried-layer resistance, both measurable in a small number of characterization runs. Fissore and colleagues showed how those models are used to construct a design space: the region of shelf temperature and chamber pressure in which product temperature stays below its limit and the equipment stays within its capability [1]. The same framework is what makes cycle transfer between dryers a calculation rather than a guess [2].

Data-driven methods then attach to the parts of the problem mechanism does not cover well. Machine learning models trained on spectral data have been used to estimate residual moisture in freeze-dired product, which supports a faster and less destructive endpoint check than sampling vials [3]. On the spray-drying side, data-driven models built on routine process monitoring have been used to predict particle size from process conditions, narrowing the number of runs needed to hit a target profile [6].

The two are complementary: mechanism gives structure and extrapolation, data gives correction and the messy empirical relationships.

What the workflow looks like

• Characterize the formulation first — collapse temperature, glass transition of the freeze-concentrate, and the excipient system — because those set the constraints the model has to respect.
• Measure vial heat transfer and product resistance in a small set of instrumented runs.
• Build the primary-drying model and compute the design space of shelf temperature and pressure that keeps product temperature under its limit [1].
• Choose an operating point inside that space with deliberate margin, not on its edge.
• Run the cycle with in-process monitoring, and compare observed product temperature and drying time against prediction; discrepancies are information about the model, not noise to be ignored.
• Confirm with the attributes that decide the outcome: residual moisture, cake appearance, reconstitution, aggregation, potency, and stability on storage.

How it works in practice

• What data goes in. For the mechanistic model: vial heat-transfer coefficient, product resistance as a function of dried-layer thickness, shelf temperature, chamber pressure, and fill volume. For the data-driven endpoint check: near-infrared (NIR) spectra collected through the vial or inline during drying, paired with residual-moisture reference measurements [3]. For spray drying: inlet/outlet temperature, feed rate, atomization pressure, and excipient composition, paired with measured particle size and residual moisture [6].
• What the model predicts. The mechanistic model predicts product temperature and primary-drying time for a given shelf temperature and pressure. The NIR model predicts residual moisture without opening vials. The spray-drying model predicts particle size and residual moisture from process settings.
• Technique or model family. Primary drying uses first-principles heat-and-mass-transfer equations. Moisture and particle-size predictions typically use multivariate regression or ensemble methods (for example, partial least squares or gradient-boosted trees) trained on matched process-sensor and lab-assay data.
• How it is validated. Predicted product temperature and drying time are compared against thermocouple and manometric measurements in instrumented runs. NIR moisture predictions are checked against Karl Fischer or gravimetric reference assays on the same lots. Spray-drying models are validated on held-out batches and, critically, on batches run at a different scale or season.
• What the team does with the output. The mechanistic design space narrows the operating window before any full batch is run. Once validated and authorized under the site's quality system, the NIR endpoint check lets the team end cycles based on measured moisture rather than fixed time. The spray-drying model reduces the number of factorial runs needed to hit a target particle-size distribution.
• A concrete example. Input: 10 mL vial, fill volume 2.0 mL, shelf temperature -25 °C, chamber pressure 100 mTorr, measured product resistance curve. Mechanistic model output: product temperature stays below collapse temperature, predicted primary drying time 42 h. NIR model output at cycle end: residual moisture 1.1 %, within the 1.0–1.5 % target. Once the method is validated and written into the approved specification, the quality unit can use that reading toward its release decision without extra lab sampling.

Where it goes wrong

Treating the design space as validated because it is calculated is the classic error. A model built on one vial type, one fill volume, and one dryer describes that configuration; change the vial, the load, or the equipment and the heat transfer term changes with it [2].

Edge-of-container and edge-of-load effects are a related trap. Vials at the shelf edge run warmer than centre vials, so a cycle designed against average behaviour can put a fraction of the batch above its collapse temperature while the model reports comfort.

Optimizing for cycle time alone is the third. A shorter cycle that leaves higher residual moisture may look excellent at release and fail at twelve months, because moisture and storage stability are linked. Stability data, not drying time, is the arbiter.

There is also a regulatory dimension. Models used to support manufacturing decisions in a regulated context are expected to be justified, documented, and maintained under change control, with the level of rigour matched to their influence on product quality [4][5].

What good looks like

Strong programmes describe the process in terms of product attributes — product temperature history, residual moisture, potency retention — and use settings only as the means to reach them. They state the assumptions behind the model, including vial type, fill, and load configuration, and re-verify when any of those change.

They keep the human decision explicit: the model proposes an operating window, the formulation and process team selects the point, and the quality system governs what is run. They also plan the confirmation up front, so that model predictions are tested against measured product temperature and stability rather than accepted because the cycle finished without a visible defect.

Questions to ask before you start

• Do you know the collapse temperature and glass transition of the actual formulation, or are you relying on values for a similar one?
• Which model inputs — vial heat transfer, product resistance — have you measured, and which are assumed?
• How will edge-of-load vials be represented in the design space, not just average vils?
• What stability-indicating attributes will judge the optimized cycle, and over what time frame?
• If the model informs a regulated process, how will it be documented, justified, and kept under change control?

Sources

1. Fissore, Pisano and Barresi, Advanced approach to build the design space for the primary drying of a pharmaceutical freeze-drying process, Journal of Pharmaceutical Sciences, 2012.
2. Fissore and Barresi, Quality by Design: Scale-Up of Freeze-Drying Cycles in Pharmaceutical Industry, AAPS PharmSciTech, 2013.
3. Use of machine learning tools and NIR spectra to estimate residual moisture in freeze-dried products, 2023.
4. ICH, Q8(R2) Pharmaceutical Development, 2009.
5. US FDA, Guide to Inspections of Lyophilization of Parenterals, 1993.
6. Data-Driven Modeling of the Spray Drying Process: Process Monitoring and Prediction of the Particle Size in Pharmaceutical Production, ACS Omega, 2024.